Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-02-22 @ 6:43 PM
Study NCT ID:
NCT02331303
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2015-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Drug Utilization Study of Radium-223 in Sweden
Sponsor:
Bayer
Organization:
Study Overview
Official Title:
A Drug Utilization Study of Xofigo Use in Sweden
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to evaluate the extent of potential off-label use of Xofigo in Sweden.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: